July 24, 2025, St. Louis, Missouri — Future Medical Products LLC is pleased to announce the launch of PBME Topical (“Pure Bone Marrow Exosomes”). PBME Topical is a cosmetic product in compliance with the Modernization of Cosmetics Regulation Act of 2022 (MoCRA).
PBME Topical consists of isolated exosomes from mesenchymal stem cells, the most studied cell in science. These exosomes are composed of phospholipid bilayers with transmembrane proteins and receptors, integrated growth factors, in addition to micro-RNA and messenger-RNA. Exosomes are naturally found in every part of the body, but the source of the exosomes intended for aesthetics, as well as regenerative medicine, is critical. Bone marrow exosomes are considered by some to be the purest form of stem cell therapy without the cell.
Topical Exosomes are between 30nm and 150nm in size. Exosomes are extracellular nano-particles that are 1/1000 the size of a cell and contain no DNA or mitochondria.
Each 5mL vial of PMBE Topical is manufactured utilizing the cGMP process. “GMP” is the applicable set of regulatory guidelines and quality control standards designed to ensure that Topical Cosmetic Products are consistently manufactured and controlled to meet quality and safety standards that protect consumer health. PBME Topical is sterile filtered and designed to meet the United States Pharmacopeia (USP<71>) sterility requirements as well as extracellular vesicle characterization to deliver a minimum of 50 billion exosomes per vial.
Each vial of PBME Topical is consistent and standardized with proven bioactivity and viability of growth factors. The revolution of cosmetic exosomes is here and PBME Topical is leading the charge.
Go to FUTUREMEDICALPRODUCTS.com or PUREBME.com for more information.
- If interested in placing an order, please contact orders@futuremedicalproducts.com
- If interested in selling this product, please contact admin@futuremedicalproducts.com
About Future Medical Products LLC
Future Medical Products, LLC, operations and order fulfillment center are located in St. Louis, Missouri. FMP is a market leading innovator and manufacturer of exosomes, cosmetics and specializes in the commercialization of medical devices, compliant with FDA standards.